IC
ITCI

IEQ Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

IEQ Capital’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-36,845
Closed -$4.86M – 2031
2025
Q1 		$4.86M Buy
36,845
+4,447
+14% +$554K 0.04% 351
2024
Q4 		$2.71M Buy
32,398
+26,708
+469% +$2.19M 0.03% 427
2024
Q3 		$416K Buy
+5,690
New +$428K 0.01% 812

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

IEQ Capital's ITCI Position: Q2 2025 in Review

IEQ Capital sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 36,845 shares — an estimated $4.86M sold.

IEQ Capital first reported a position in ITCI in Q3 2024 and held it in 3 quarters. The position peaked at $4.86M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • IEQ Capital reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • IEQ Capital sold 36,845 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $4.86M.
  • IEQ Capital first reported a position in Intra-Cellular Therapies Inc. in Q3 2024 and held it in 3 quarters.
  • IEQ Capital's Intra-Cellular Therapies Inc. position peaked at $4.86M in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on IEQ Capital's 13F filing for Q2 2025, filed 14 Aug 2025.